Global Hemostats Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Scope of the Report:
This report focuses on the Hemostats in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
Major manufacturers in the market are Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard and The Medicines Company.
To grab more market, the little companies have to expand the technology, capital investment and brand influence. To meet the challenge of the little companies and keep their leading stage, leading companies need to increase the technology innovation and speed up the product upgrading. In the future, Hemostats market will be a market of fierce competition.
In order to feed the changing technical requirements, Hemostats manufacturers need to pay attention to the technical innovation. In future, Thrombin-Based Hemostats will be the technology trends of Hemostats.
The worldwide market for Hemostats is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 3070 million US$ in 2023, from 2160 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Ethicon, Inc.
Pfizer, Inc.
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics, Inc.
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions, Inc.
Marine Polymer Technologies, Inc.
Z-Medica, LLC
CryoLife, Inc.
BioCer Entwicklungs-GmbH.
Biom'Up SAS

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats

Market Segment by Applications, can be divided into
Prehospital Treatment
Hospital Treatment

There are 15 Chapters to deeply display the global Hemostats market.
Chapter 1, to describe Hemostats Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hemostats, with sales, revenue, and price of Hemostats, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hemostats, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hemostats market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hemostats sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions